Form S-3ASR RELMADA THERAPEUTICS,
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/15/2026
- US stock futures rise on Iran deal optimism; oil tumbles
- Fox to acquire Roku for $22 billion to create streaming and live content giant
- SpaceX extends gains premarket after biggest IPO ever values it at $2.1 trillion
- These 2 space stocks were upgraded at KeyBanc today
- Morgan Stanley outlines sectors set to benefit from market broadening
- This company's long-term growth remains underappreciated: Wolfe
- This stock is the biggest winner from higher voltages in the Datacenter IT room
- Johnson & Johnson shows positive results for TALVEY-DARZALEX drug combination
- Lilly's Jaypirca reduces disease progression risk by 45% in CLL study
- Why does Barclays say it’s time to buy this Spanish stock?
Relmada Therapeutics (RLMD) files mixed shelf
May 13, 2026 4:59 PM EDTRelmada Therapeutics (NASDAQ: RLMD) has filed mixed shelf of:
COMMON STOCK
PREFERRED STOCK
WARRANTS
SUBSCRIPTION RIGHTS
DEPOSITARY SHARES
PURCHASE CONTRACTS
UNITS
... More